Medtronic Neuromodulation is recalling approximately 4,365 units of its A820 myPTM software application, which is used by patients to manage their Medtronic SynchroMed Pump and Infusion Systems. This recall was issued because the app may take longer than expected to interact with the implanted pump, causing delays in monitoring or therapy adjustments. While Medtronic has received product complaints regarding this performance issue, no specific injuries have been reported. Consumers using this application should contact their healthcare provider or Medtronic for instructions on how to handle software interactions.
The software app may respond slowly when communicating with the implanted infusion pump, which could delay a patient's ability to manage their therapy or receive necessary medication. This slow interaction could lead to an interruption in treatment or delayed monitoring of the implant's status.
You have 2 options:
Associated with Medtronic SynchroMed Pump and Infusion System.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.